Drug details
Inflectra (infliximab-dyyb intravenous injection)
type of DMARDs, TNF Inhibitors, Monoclonal Antibodies
Inflectra (infliximab-dyyb) for Injection is a tumor necrosis factor (TNF) blocker indicated for reducing signs and symptoms of Crohn's disease, pediatric Crohn's disease, ulcerative colitis, rheumatoid arthritis (in combination with methotrexate), ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
The drug is often used to treat Ankylosing spondylitis , Psoriatic arthritis , Ulcerative colitis .
This drug may have the following side effects:
- nausea
- rash
- itching
- fever
- diarrhea
- joint pain
- runny or stuffy nose
- headache
- upper respiratory infections
- sinus infections
- sore throat
- cough
- bronchitis
- infusion-related reactions
- abdominal pain
- indigestion
- fatigue
- pain
- oral thrush
- urinary tract infection, and
- high blood pressure (hypertension)
The following drugs are related to Inflectra, either as a replacement or used together:
- Actemra (tocilizumab injection)
- Humira (adalimumab injection solution for subcutaneous administration)
- Amjevita (adalimumab-atto)
- Otezla (apremilast tablets)
- Arcalyst (rilonacept)
- Ridaura (auranofin)
- Azulfidine EN-Tabs (sulfasalazine delayed release tablets)
- Olumiant (baricitinib tablets)
- Uceris (budesonide rectal foam)
- Sotyktu (deucravacitinib tablets)
- Enbrel (etanercept)
- Simponi Aria (golimumab for infusion)
- Simponi Injection (golimumab injection)
- Ultravate X Cream (halobetasol propionate)
- Remicade (infliximab)
- Renflexis (infliximab-abda injection)
- Kevzara (sarilumab injection, for subcutaneous use)
- Rituxan Hycela (rituximab and hyaluronidase human injection)
- Zoryve (roflumilast cream)